{"product_id":"scripps-6th-annual-scripps-cardiomyopathy-and-cardio-oncology-symposium-2023","title":"Scripps 6th Annual Scripps Cardiomyopathy and Cardio-Oncology Symposium 2023","description":"\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cbr\u003e\u003cbr\u003eThe Scripps Cardiomyopathy and Cardio-Oncology Symposium is designed to provide a state-of-the-art, comprehensive curriculum that addresses important clinical topics relevant to cardiomyopathy and the cardiovascular health of cancer patients and survivors. Cardio-oncology is an important and emerging field of medicine resulting from new or unexpected cardiovascular toxicities many cancer survivors are now experiencing because of their cancer treatments. In addition, cardiac amyloidosis is a burgeoning disease with exciting new treatments.\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eNationally recognized faculty in the fields of cardiology and oncology will discuss challenging topics related to common cardiomyopathies as well as current best practices for diagnosing, treating and managing patients. The goal of the conference is for participants to return to their practice equipped with the latest evidence base and practical information to improve patient care.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eEducational Objectives\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eAfter attending this live activity, participants should be able to:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eEvaluate current and emerging treatment options for cardiac amyloidosis.\u003c\/li\u003e\n\u003cli\u003eDiscuss diagnosis and treatment considerations for patients with cardiac sarcoidosis.\u003c\/li\u003e\n\u003cli\u003eAssess the importance of genetic testing and treatment for genetic cardiomyopathies including hypertrophic cardiomyopathy.\u003c\/li\u003e\n\u003cli\u003eAnalyze best practices in the multidisciplinary monitoring and management of cardiac toxicity in patients undergoing cancer therapy.\u003c\/li\u003e\n\u003cli\u003eEmploy management strategies for venous thromboembolism and other cardiovascular complications that may occur in patients with cancer.\u003c\/li\u003e\n\u003cli\u003eDemonstrate the importance of ongoing cardiac disease monitoring in cancer survivors.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eTarget Audience\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eCardiologists\u003c\/li\u003e\n\u003cli\u003eOncologists\u003c\/li\u003e\n\u003cli\u003eInternists\u003c\/li\u003e\n\u003cli\u003eRN, NP, PA\u003c\/li\u003e\n\u003cli\u003eSonographers\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e+ Topics:\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003ebrochure_cmp23.pdf\u003c\/li\u003e\n\u003cli\u003eSESSION I CARDIOMYOPATHIES AL Amyloidosis Making the Diagnosis.mp4\u003c\/li\u003e\n\u003cli\u003eSESSION I CARDIOMYOPATHIES Cardiac Sarcoidosis Making the Diagnosis.mp4\u003c\/li\u003e\n\u003cli\u003eSESSION I CARDIOMYOPATHIES Cardiac Sarcoidosis Therapeutic Principles.mp4\u003c\/li\u003e\n\u003cli\u003eSESSION I CARDIOMYOPATHIES Current and Emerging Treatments for AL Amyloidosis.mp4\u003c\/li\u003e\n\u003cli\u003eSESSION I CARDIOMYOPATHIES Current Treatments for ATTR.mp4\u003c\/li\u003e\n\u003cli\u003eSESSION I CARDIOMYOPATHIES Emerging Therapies for ATTR.mp4\u003c\/li\u003e\n\u003cli\u003eSESSION I CARDIOMYOPATHIES Genetic Cardiomyopathies Who to Screen and What to Look For.mp4\u003c\/li\u003e\n\u003cli\u003eSESSION I CARDIOMYOPATHIES How To Make the Diagnosis of ATTR.mp4\u003c\/li\u003e\n\u003cli\u003eSESSION I CARDIOMYOPATHIES Hypertrophic Cardiomyopathy Diagnosis and Treatment.mp4\u003c\/li\u003e\n\u003cli\u003eSESSION I CARDIOMYOPATHIES Panel Discussion Q\u0026amp;A.mp4\u003c\/li\u003e\n\u003cli\u003eSESSION I CARDIOMYOPATHIES Transthyretin Amyloidosis (ATTR) Who to Suspect.mp4\u003c\/li\u003e\n\u003cli\u003eSESSION II CARDIO-ONCOLOGY Best Practices in Surveillance and Management of Cardiac Toxicity in the Cancer Patient The Cardiologist’s Perspective.mp4\u003c\/li\u003e\n\u003cli\u003eSESSION II CARDIO-ONCOLOGY Best Practices in Surveillance and Management of Cardiac Toxicity in the Cancer Patient The Oncologist’s Perspective.mp4\u003c\/li\u003e\n\u003cli\u003eSESSION II CARDIO-ONCOLOGY Cardiac Disease Monitoring in Cancer Survivors.mp4\u003c\/li\u003e\n\u003cli\u003eSESSION II CARDIO-ONCOLOGY Incorporating Multi-Modality Imaging in Cardio-Oncology.mp4\u003c\/li\u003e\n\u003cli\u003eSESSION II CARDIO-ONCOLOGY Management of End-Stage Heart Failure in the Cancer Survivor.mp4\u003c\/li\u003e\n\u003cli\u003eSESSION II CARDIO-ONCOLOGY Management of VTE in the Cancer Patient.mp4\u003c\/li\u003e\n\u003cli\u003eSESSION II CARDIO-ONCOLOGY Panel Discussion Q\u0026amp;A.mp4\u003c\/li\u003e\n\u003cli\u003eSESSION II CARDIO-ONCOLOGY Strategies to Minimize Radiation-Induced Heart Disease.mp4\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954372055138,"sku":"MED-AMB02093","price":40.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Scripps-6th-Annual-Scripps-Cardiomyopathy-and-Cardio-Oncology-Symposium-2023.webp?v=1779374826","url":"https:\/\/meducourse.com\/products\/scripps-6th-annual-scripps-cardiomyopathy-and-cardio-oncology-symposium-2023","provider":"Meducourse","version":"1.0","type":"link"}